Literature DB >> 3280426

Plasminogen: a brief introduction into its biochemistry and function.

C Miyashita1, E Wenzel, M Heiden.   

Abstract

Human plasminogen is a beta-globulin (2% carbohydrate, molecular weight 90 KD), which in its native form has NH2-terminal glutamic acid (Glu-plasminogen) whose primary structure is known (31, 37, 38). From human plasma plasminogen can easily be isolated by affinity chromatography techniques (10, 25, and Table 1). Plasminogen is synthesized in many organs. The production site of the zymogen may be the liver (21), the eosinophiles (3) or the kidney (15). The plasma-plasminogen level is low in newborns (22) and even lower in the premature infant (2). In healthy adults it is found in plasma or serum in a concentration of 200 mg/l (= 2 microM, 22, 39). The half-life of the native (Glu-) plasminogen is 2.24 +/- 0.29 days (6). Two types of Glu-plasminogen occur in human plasma, which differ in their carbohydrate composition as well as in their content of sialic acid. Genetic variants (see Mayr, 3.1.); of plasminogen have been reported (16) after isoelectric focusing of human plasma in polyacrylamide gels. Three patterns were found, two completely different and the third most likely a mixture of the other two. Characteristical functional properties of plasminogen are related to its molecular structure, e.g. its in vivo specificity for fibrin in contrast to the fairly unspecific in vitro activity of plasmin. Glu-plasminogen is easily converted by limited plasmic digestion to modified forms with NH2-terminal lysine, valine or methionine, which are commonly designated "Lys-plasminogen" displaying a plasma half-life time of 0.8 days.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280426     DOI: 10.1159/000215824

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  15 in total

1.  Plasminogen is a complement inhibitor.

Authors:  Diana Barthel; Susann Schindler; Peter F Zipfel
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

2.  Plasminogen in proliferative vitreoretinal disorders.

Authors:  P Esser; K Heimann; K U Bartz-Schmidt; P Walter; R Krott; M Weller
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

3.  Borrelia burgdorferi induces secretion of pro-urokinase-type plasminogen activator by human monocytes.

Authors:  H Fuchs; M M Simon; R Wallich; M Bechtel; M D Kramer
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

4.  A disposable system for rapid purification of autologous plasmin as an adjunct to vitrectomy - performance and safety profile.

Authors:  Martin Hermel; Wendelin Dailey; Michael Trese; Michael K Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-03       Impact factor: 3.117

5.  alpha 2-Antiplasmin and plasminogen activator inhibitors in healing human skin wounds.

Authors:  B M Schaefer; K Maier; U Eickhoff; M Bechtel; M D Kramer
Journal:  Arch Dermatol Res       Date:  1996-03       Impact factor: 3.017

6.  A Novel Interaction between Complement Inhibitor C4b-binding Protein and Plasminogen That Enhances Plasminogen Activation.

Authors:  Vaibhav Agarwal; Simone Talens; Alexander M Grandits; Anna M Blom
Journal:  J Biol Chem       Date:  2015-06-11       Impact factor: 5.157

7.  Cytosolic proteins contribute to surface plasminogen recruitment of Neisseria meningitidis.

Authors:  Andreas Knaust; Martin V R Weber; Sven Hammerschmidt; Simone Bergmann; Matthias Frosch; Oliver Kurzai
Journal:  J Bacteriol       Date:  2007-02-16       Impact factor: 3.490

8.  The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor.

Authors:  H Fuchs; R Wallich; M M Simon; M D Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

9.  Plasminogen activation in healing human wounds.

Authors:  B M Schäfer; K Maier; U Eickhoff; R F Todd; M D Kramer
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

10.  Effect of intravitreal plasmin on vitreous removal through a 25-gauge cutting system in the rabbit in vivo.

Authors:  Martin Hermel; Jonathan Prenner; Motaz Alabdulrazzak; Wendy Dailey; Michael Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.